About 5 results found for searched term "ROC-325" (0.141 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M6260 | ROC-325 | Autophagy |
| ROC-325 is an orally available novel inhibitor of lysosomal-mediated autophagy which diminishes AML cell viability with the IC50 range of 0.7-2.2 μM. | ||
| M14642 | 2'-Deoxycytidine hydrochloride | Metabolite/Endogenous Metabolite |
| 2'-Deoxycytidine monohydrochloride; Deoxycytidine hydrochloride; NSC 83251 | ||
| 2'-Deoxycytidine hydrochloride is composed of the purine nucleoside guanine linked by its N9 nitrogen to the C1 carbon of deoxyribose. | ||
| M28819 | AG-1478 hydrochloride | EGFR/HER2 |
| Tyrphostin AG-1478 hydrochloride; NSC 693255 hydrochloride | ||
| AG-1478 hydrochloride (Tyrphostin AG-1478 hydrochloride) is a selective EGFR tyrosine kinase inhibitor with IC50 of 3 nM. AG-1478 hydrochloride has antiviral effects against HCV and encephalomyocarditis virus (EMCV). | ||
| M13956 | Aprocitentan | Endothelin Receptor |
| ACT-132577 | ||
| Aprocitentan (ACT-132577) is the major and pharmacologically active metabolite of Macitentan. Aprocitentan is dual ETA/ETB antagonist with IC50s of 3.4 nM and 987 nM, and pA2 valus of 6.7 and 5.5, respectively. | ||
| M49536 | Rho-Kinase-IN-1 | ROCK |
| Rho-Kinase-IN-1 is a Rho kinase (ROCK) inhibitor (Ki values of 30.5 and 3.9 nM for ROCK1 and ROCK2, respectively) extracted from US20090325960A1, compound 1.008. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
